378 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
, the Company's GAAP effective tax rate (ETR) was (3.0%), compared to 4.7% in the first quarter of 2023. The GAAP ETR in the first quarter of 2024 … million
$780–$880 million
GAAP effective tax rate
Non-GAAP effective tax rate(a)
Unchanged
* GAAP and non-GAAP amounts are equivalent as no non-GAAP
8-K
EX-99.1
t7dgetm4ff
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
nr58d ttka
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
y3p3oc k8r22592
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
un80c1r3u7
5 Oct 23
Results of Operations and Financial Condition
4:04pm
SC TO-T
EX-99
qk3pkrdzu6f5yeo2vmf7
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
t0w5i9hl
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
ku15gnsewddbb
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
jmb0fwmktjv3zq
25 Aug 23
Third party tender offer statement
7:46am
8-K
EX-99.1
4yn07jvb ftlfv6
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
szzj1sem
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am